Leaflet AGGRENOX 25mg / 200mg modified release capsules
Indicated for: cardiovascular prevention
Route of administration: oral
Substance: acetylsalicylic acid + dipyridamole (antiplatelet agents)
ATC: B01AC30 (Blood and blood forming organs | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin)
This medicine may have important interactions with other medicines.
This medicine may affect the kidneys.
Use during pregnancy only on medical advice.
Use in children only as recommended in the leaflet or by a doctor.
This medicine may increase the risk of bleeding.
This medicine may increase the risk of ulcer or gastrointestinal bleeding.
Acetylsalicylic acid + dipyridamole is a combination medication primarily used for the prevention of ischemic strokes in patients who have already experienced such an event or are at high risk. This combination works by preventing blood clot formation and improving blood flow to the brain.
Acetylsalicylic acid acts as an antiplatelet agent, reducing the ability of platelets to form clots, while dipyridamole enhances its effect by inhibiting adenosine uptake, leading to blood vessel dilation and a reduced risk of thrombosis.
Side effects may include headaches, dizziness, gastric irritation, nausea, or an increased risk of bleeding. It is important for patients to follow their doctor’s instructions and inform the specialist about any pre-existing conditions or medications, as this combination may interact with other treatments.
General data about AGGRENOX 25mg / 200mg
- Substance: acetylsalicylic acid + dipyridamole
- Date of latest medicines list: 01-08-2018
- Product code: W59803002
- Concentration: 25mg / 200mg
- Pharmaceutical form: modified release capsules
- Quantity: 60
- Product type: Original
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.